Sonoma Pharmaceuticals Inc (SNOA) Stock Price, Quote & News

Company Profile

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild t...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 800 759 9305

Website: sonomapharma.com

Address:

5445 Conestoga Court, Suite 150, Boulder, United States

joe77w Apr. 25 at 12:48 PM

$SNOA 1) this was a "firm commitment" offering not a best efforts one; 2) offering closing on Monday 27; 3) Aquanil Ad Sales update likely at any moment. New investors subscribing at 1.35 usd are already gaining because have bought stock way below tangible book value per share.

0 · Reply

joe77w Apr. 25 at 12:41 PM

$SNOA I would not be surprised if news out next coming week, stock would double, so warrants exercised and Company well funded. Just my opinion, net tangible book value per share higher than current pps. Do your dd, this Is not a financial advice. Glty

0 · Reply

The_Scientist Apr. 24 at 6:29 PM

$SNOA a complete overreaction. A really good opportunity to 2x your money from here.

0 · Reply

SQUEAKSBANDIT Apr. 24 at 5:51 PM

$SNOA this offering just added over 300% to the fully diluted share count where to from here? more time in penny land? followed by another reverse

1 · Reply

TradPoof Apr. 24 at 4:34 PM

$SNOA Overreacting, 👀 add on dips

0 · Reply

le_ghoast Apr. 24 at 4:18 PM

$SNOA ez money

0 · Reply

DisneyPalaceTrades Apr. 24 at 4:12 PM

$SNOA on the move

0 · Reply

Bli1 Apr. 24 at 3:19 PM

$SNOA it should break out soon from this flatlining. Real co with real sales.

1 · Reply

stockanalysis_ Apr. 24 at 2:13 PM

Losers Today: $AUUD $CHSN $SNOA $SKLZ $AIXI Download this screener: https://stockanalysis.com/markets/losers/?ref=saveontrading

0 · Reply

focafoca99 Apr. 24 at 1:51 PM

$SNOA packages a $4.X million public offering of common stock plus warrants at $1.35 per share. https://www.rapidticker.com/news/snoa-sonoma-pharmaceuticals-announces-pricing-of-5c3314

0 · Reply

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

Mar 24, 2026, 8:30 AM EDT - 4 weeks ago

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

Mar 18, 2026, 8:30 AM EDT - 5 weeks ago

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

Feb 10, 2026, 4:10 PM EST - 2 months ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Jan 28, 2026, 4:15 PM EST - 3 months ago

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

Nov 13, 2025, 8:30 AM EST - 5 months ago

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Nov 6, 2025, 4:01 PM EST - 6 months ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

Nov 4, 2025, 8:56 AM EST - 6 months ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

Oct 14, 2025, 8:30 AM EDT - 6 months ago

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

Oct 7, 2025, 8:30 AM EDT - 7 months ago

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

Sep 25, 2025, 4:01 PM EDT - 7 months ago

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Aug 26, 2025, 8:30 AM EDT - 8 months ago

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 13, 2025, 4:01 PM EDT - 9 months ago

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Aug 7, 2025, 4:15 PM EDT - 9 months ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Jun 17, 2025, 4:10 PM EDT - 11 months ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Apr 22, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Mar 10, 2025, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Feb 25, 2025, 4:01 PM EST - 1 year ago

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Feb 5, 2025, 4:05 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Dec 5, 2024, 8:30 AM EST - 1 year ago

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Nov 21, 2024, 4:06 PM EST - 1 year ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Nov 11, 2024, 4:20 PM EST - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Nov 7, 2024, 8:45 AM EST - 1 year ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Oct 31, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Oct 22, 2024, 8:35 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Oct 21, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sep 11, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Aug 28, 2024, 6:10 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Aug 26, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Aug 21, 2024, 8:45 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Jul 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Jun 17, 2024, 5:00 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

May 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Apr 4, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Mar 28, 2024, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Mar 27, 2024, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Feb 8, 2024, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Jan 23, 2024, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

Nov 13, 2023, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Nov 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Oct 26, 2023, 9:10 AM EDT - 2 years ago

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

Aug 15, 2023, 7:30 AM EDT - 2 years ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 10, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Jun 22, 2023, 7:30 AM EDT - 3 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

joe77w Apr. 25 at 12:48 PM

0 · Reply

joe77w Apr. 25 at 12:41 PM

0 · Reply

The_Scientist Apr. 24 at 6:29 PM

$SNOA a complete overreaction. A really good opportunity to 2x your money from here.

0 · Reply

SQUEAKSBANDIT Apr. 24 at 5:51 PM

$SNOA this offering just added over 300% to the fully diluted share count where to from here? more time in penny land? followed by another reverse

1 · Reply

TradPoof Apr. 24 at 4:34 PM

$SNOA Overreacting, 👀 add on dips

0 · Reply

le_ghoast Apr. 24 at 4:18 PM

$SNOA ez money

0 · Reply

DisneyPalaceTrades Apr. 24 at 4:12 PM

$SNOA on the move

0 · Reply

Bli1 Apr. 24 at 3:19 PM

$SNOA it should break out soon from this flatlining. Real co with real sales.

1 · Reply

stockanalysis_ Apr. 24 at 2:13 PM

Losers Today: $AUUD $CHSN $SNOA $SKLZ $AIXI Download this screener: https://stockanalysis.com/markets/losers/?ref=saveontrading

0 · Reply

focafoca99 Apr. 24 at 1:51 PM

$SNOA packages a $4.X million public offering of common stock plus warrants at $1.35 per share. https://www.rapidticker.com/news/snoa-sonoma-pharmaceuticals-announces-pricing-of-5c3314

0 · Reply

trader87 Apr. 24 at 1:34 PM

$SNOA used to be the best management. pathethic pull

1 · Reply

psychohaiko Apr. 24 at 1:00 PM

@Hailight nächster Banger von Alexander orchestriert $SNOA

1 · Reply

Zaksab Apr. 24 at 1:00 PM

$SNOA Dawson James has a Stratton Oakmont feel to it lol

0 · Reply

OpenOutcrier Apr. 24 at 12:47 PM

$SNOA (-25.0% pre) Sonoma Pharmaceuticals (NASDAQ: SNOA) files S-1 for $5M unit and warrant sale https://ooc.bz/l/99957

0 · Reply

TA_Kongen Apr. 24 at 10:40 AM

$SNOA S-1 in effect now. Usually will dump offering within a day or two. Even if you wanna gamble here statisically it is a bad gamble.

0 · Reply

trader87 Apr. 24 at 10:27 AM

$SNOA it's because of it's S1, basically hard to believe they would be so foolish to double the OS without a significant pump...picked shares below 1.40

0 · Reply

TradPoof Apr. 23 at 4:34 PM

$SNOA 👀 undervalue, grab the dips. Good news & volume will send to at least $5 🤑🫰🏻😍

0 · Reply

frontiere Apr. 21 at 7:32 PM

$SNOA Sonoma now $2.30 down on >300k shares volume — but WHAT IF they and Dawson James see what is going on with broad equities and short squeeze folks here by withdrawing this S-1? Or similar tactics? Anyway, still long.

1 · Reply

Pinebox32 Apr. 21 at 1:30 PM

$BYND banger. take some profit to $SNOA $5,$6,$7 before we know it thank me later

0 · Reply

Pinebox32 Apr. 20 at 9:12 PM

$SNOA going to be a good week or two coming up. 👍🏻👍🏻👍🏻

1 · Reply

vcaelum Apr. 20 at 3:38 PM

$SNOA $5M ATM offering on April 2026 tho

0 · Reply

vcaelum Apr. 20 at 3:34 PM

$SNOA in 2.8 HARD SL 2.5

1 · Reply

Market Cap	3.12M
Revenue (ttm)	14.29M
Net Income (ttm)	-3.46M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-24.21%
Debt to Equity Ratio	0.00

Volume	5,191,500
Avg Vol	157,276
Day's Range	N/A - N/A
Shares Out	1.73M
Stochastic %K	14%
Beta	1.76
Analysts	Strong Sell
Price Target	$14.80